drugset / Trial / NCT01067807
Proellex Pharmacokinetics Bridging Study
RandomizedCrossoverOpen-labelTreatment
Summary
Healthy female subjects received a single dose of four different types of Proellex, the original 25 mg dose and three new formulations
Timeline
- Start
- 2007-06
- Primary completion
- 2007-07
- Completion
- 2007-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Telapristone Acetate | Other / unclassified | 25 mg | — |
| Subject | Telapristone Acetate | Other / unclassified | 50 mg | — |
Indications
No indication recorded.